Intimations To Stock Exchange | RPG Life Sciences
rpgls
  • Contact Us
  • Our Story
    • History and Milestones
    • Our Brand
    • Core Strengths
    • Vision, Values and Capabilities
    • Board of Directors
    • Management Team
    • Industry Awards and Recognition
  • Our Businesses
    • Business Portfolio
      • API
      • Domestic Formulations
      • International Formulations
      Manufacturing
      • Manufacturing Facilities
      • Quality
      • Environment, Health and Safety
      Scientific Overview
      • Research and Development
      • Patents
  • Therapeutic Focus
    • Nephrology
    • Cardiovascular
    • Anti-Diabetic
    • Orthopedic
    • Urology
    • Oncology
    • Rheumatology
    • Gastroenterology
    • Respiratory
    • Gynaecology and Pediatrics
    • Vitamins and Minerals
    • Neurology
    • Anti-Dengue
    • Dermatology
  • Life@RPGLS
    • Employee Connect
      Rewards and Recognition
      • Brave RPGLS Covid Warriors
      • Great Place To Work
      • Team Awards
      • Employee Awards
      Human Resources
      • Jobs At RPGLS
      • Company Events
      • Learning and Development
      CSR
      • Corporate Social Responsibility
      Explore Us
      Happiness Matters!!
  • Investors
    • Financial Results
      • Audited Financial Results
      • Quarterly Financial Results
      Company Presentations
      • Investor Presentations
      • Earnings Call
      • Press Release
      Mandatory Disclosures
      • Code and Policies
      Shareholders Information
      • Shareholding Pattern
      • Concepts and Procedure
      • Corporate Governance Reports
      • Annual Reports
      • Subsidiary Financials
      • Intimation to Stock Exchange
      • Notices of Board Meetings
      • Outcome of Board Meetings
      • AGM & Postal Ballot
      • Unpaid Dividend List
      • TDS on Dividend Communication
      • Forms related to Physical Shares
      • Newspaper Publications
      • Market Tracker and Credit Rating
      Investor Relations
      • Investor Education and Protection Fund
      • Investor Grievance
      • Investor Contacts
      • Investor Meets
      Committees Composition
      • Audit Committee
      • Risk Management Committee
      • Stakeholders Relationship Committee
      • Nomination & Remuneration Committee
      • SCSR Committee
      DISCLOSURES UNDER REGULATION 46 OF LODR
      • Disclosures under regulation 46 of LODR
  • Media
    • Online News and Print Media
    • RPGLS @ Industry Platforms

INTIMATIONS TO STOCK EXCHANGE
  • Home
  • intimations to stock exchange

Sr. No. File Name (Click to Download)
106 Intimation about closing of Trading Window September 30, 2022
107 Intimation for Loss of Certificate September 23, 2022
108 Intimation for loss of Certificate September 19, 2022
109 Intimation of Issue of Duplicate Certificate September 13, 2022
110 Intimation for loss of Certificate September 09, 2022
111 Intimation for loss of Certificate August 30, 2022
112 Intimation of Loss of Share Certificate July 14,2022
113 Intimation of Record Date - July 15, 2022
114 Intimation about closing of Trading Window June 30, 2022
115 Intimation of Loss of Share Certificate June 3,2022
116 Intimation of Loss of Share Certificate June 2,2022
117 Disclosure Regulation 23(9) - Related Party for Half year ended March 31, 2022
118 Annual Secretarial Compliance Report March 31, 2022
119 Intimation of Issue of Duplicate Certificate 29.04.22
120 Intimation of Loss of Share Certificate March 8, 2022
  • Prev
  • 1
  • 2
  • ...
  • 6
  • 7
  • 8
  • 9
  • 10
  • ..
  • 12
  • 13
  • Next

Investors Information

Annual Conference Videos
  • June 16, 2021
  • Your browser does not support HTML5 video.
Company Presentations
  • Investor Presentations
  • Corporate Presentations
  • Earnings Call
  • Press Release
Financial Results
  • Audited Financial Results
  • Quarterly Financial Results
  • Dividend Declarations
Investor Relations
  • Investor Education and Protection Fund
  • Investor Grievance
  • Investor Contacts
  • Investor Meets
Share Holders Information
  • Shareholding Pattern
  • Concepts and Procedure
  • Corporate Governance Reports
  • Annual Reports
  • Intimation to Stock Exchange
  • Notices of Board Meetings
  • Outcome of Board Meetings
  • AGM & Postal Ballot
  • Unpaid Dividend List
  • TDS on dividend communication
  • Forms related to Physical Shares
  • Reg. 46 SEBI (LODR)
  • Newspaper Publications
  • Market tracker
Board Committees
  • Audit Committee
  • Risk Management Committee
  • Stakeholders Relationship Committee
  • Nomination & Remuneration Committee
  • SCSR Committee
Mandatory Disclosures
  • Code and Policies
  • Disclosures under regulation 46 of LODR
Get in Touch

QUICK LINKS

Vision

Quality

History and Milestones

Company Awards

Manufacturing Facilities

Research and Development

Offline PDF form
Drugs Safety – Adverse Event Reporting

Contact Us

  • Address:
    RPG Life Sciences Limited,
    RPG HOUSE, 463, Dr. Annie Besant Road, Worli,
    Mumbai - 400030, India

  • Phone: 91-22-69757100

  • Email:

Follow Us




Porto Website Template

RPG Life Sciences Limited © Copyright 2025-26. All Rights Reserved.

  • Privacy Policy
  • Cookie Policy
  • Terms and Conditions
  • Sitemap